Ractigen Therapeutics to Present First-in-Human RNA Activation Data in Duchenne Muscular Dystrophy as a Late-Breaking Oral Presentation at the 31st Annual Congress of the World Muscle Society
- Written by PR Newswire
- Late-Breaking selection at the 31st Annual World Muscle Society Congress — a designation reserved for findings the program committee determines to be of immediate importance to the field
- Presentation expected to provide the first clinical evidence that a small activating RNA (saRNA) can upregulate an endogenous target protein in patients with...














